291 related articles for article (PubMed ID: 27845951)
1. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
2. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
McCowan C; Munro AJ; Donnan PT; Steele RJ
Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
4. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.
Walker AJ; Grainge MJ; Card TR
Br J Cancer; 2012 Oct; 107(9):1602-7. PubMed ID: 23011483
[TBL] [Abstract][Full Text] [Related]
6. Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
Ong G; Davis TM; Davis WA
Diabetes Care; 2010 Feb; 33(2):317-21. PubMed ID: 19918016
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
8. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
[TBL] [Abstract][Full Text] [Related]
9. Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
Int J Cardiol; 2017 Dec; 248():376-381. PubMed ID: 28942878
[TBL] [Abstract][Full Text] [Related]
10. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004
[TBL] [Abstract][Full Text] [Related]
11. Aspirin use and survival after diagnosis of colorectal cancer.
Chan AT; Ogino S; Fuchs CS
JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
[TBL] [Abstract][Full Text] [Related]
12. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML
Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482
[TBL] [Abstract][Full Text] [Related]
13. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
González-Pérez A; Sáez ME; Johansson S; Nagy P; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):215-222. PubMed ID: 27921360
[TBL] [Abstract][Full Text] [Related]
14. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
Rothwell PM; Cook NR; Gaziano JM; Price JF; Belch JFF; Roncaglioni MC; Morimoto T; Mehta Z
Lancet; 2018 Aug; 392(10145):387-399. PubMed ID: 30017552
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
[TBL] [Abstract][Full Text] [Related]
16. Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.
Bains SJ; Mahic M; Myklebust TÅ; Småstuen MC; Yaqub S; Dørum LM; Bjørnbeth BA; Møller B; Brudvik KW; Taskén K
J Clin Oncol; 2016 Jul; 34(21):2501-8. PubMed ID: 27247217
[TBL] [Abstract][Full Text] [Related]
17. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
Lamotte M; Annemans L; Evers T; Kubin M
Pharmacoeconomics; 2006; 24(2):155-69. PubMed ID: 16460136
[TBL] [Abstract][Full Text] [Related]
18. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.
Tsoi KK; Chan FC; Hirai HW; Sung JJ
J Gastroenterol Hepatol; 2018 Oct; 33(10):1728-1736. PubMed ID: 29665624
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study.
Sundström J; Hedberg J; Thuresson M; Aarskog P; Johannesen KM; Oldgren J
Circulation; 2017 Sep; 136(13):1183-1192. PubMed ID: 28947478
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
